An interventional study of Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS) in Autism Spectrum Disorder and Autism, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 6 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-25.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Autistic Disorder by Stanford University — 16 open to participants now, 16 under way, none of them phase 3. Autistic Disorder · Stanford University.
Among the 33 studies in Autistic Disorder by Stanford University, this one is the 24th largest by planned enrollment, is one of 3 that started in 2025, is one of 21 with no phase, reaches primary completion later than 4 of the 15 other live ones, and was the 29th registered.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
Browse Autistic Disorder studies →16 of the 33 studies in Autistic Disorder by Stanford University are open now, in 1 country. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 2–5 · Healthy volunteers
Stanford University · Sites in United States
Ages 6–12
Stanford University · Sites in United States
Ages 4–17 · Healthy volunteers
Stanford University · Sites in United States
Ages 3–35
Stanford University · Sites in United States
Ages 11–14
By country, each count listing its studies:
Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.
This study: 6 Years to 11 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 12 · Phase 3 1
First in 2008; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Median enrollment 48 across the 33 interventional studies. Of the 16 that completed or were terminated, 7 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
4 of the studies in Autistic Disorder by Stanford University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06627205Stanford UniversitySleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism | 2026-12 |
| NCT05987774Stanford UniversityImproving Social Communication in Individuals With ASD Using AI | 2027-06-30 |
| NCT06472115Stanford UniversityParent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children | 2027-10-01 |
| NCT03583684Stanford UniversityNeuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism | 2027-11-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 33 studies in Autistic Disorder by Stanford University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism and investigate 1) whether caregivers can learn to deliver the adapted Supportive Parenting for Anxious Childhood emotions (SPACE) intervention for IS via telehealth and 2) whether children will show greater improvement in IS behaviors.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
This study's planned enrollment of 30 is below the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Browse Autistic Disorder studies →Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Eligible participants that enroll will received 16 week parent based intervention for insistence on sameness
Behavioral: Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)
This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism. This includes a 16 week protocol where caregivers meet weekly for one hour with a study therapist.
Change from baseline in parent rated Dimensional Assessment of Restricted Behavior (DARB) Scores during treatment.
DARB scores measure restricted and repetitive behaviors with higher scores indicating greater intensity.
Time frame: Screening, Baseline, Weeks 4, 8, 12, 16 and 2 month follow up
Change from baseline in clinician rated clinical global impressions scale scores during treatment.
Score Range: 1 = normal, not at all ill; 7 = among the most extremely ill patients; 1 = very much informed since the initiation of treatment; 7 = very much worse since the initiation of treatment.
Time frame: Weeks 8, 16 and 2 month follow up
Change from Baseline in Parent-Rated Anxiety as captured by the Anxiety Scale for Children with Autism Spectrum Disorder (ASC-ASD).
ASC-ASD captures anxiety with higher scores indicating greater anxiety severity across the subdomains of separation anxiety, uncertainty, performance anxiety, and anxious arousal. \[Score Range: 0-72\]
Time frame: Baseline, Week 16 and 2 month Follow up
Change in Emotion Regulation Checklist scores during treatment
The Emotion Regulation Checklist (ERC) is a 24-item measure of children's self-regulation completed by a caregiver. Items are rated along a continuum (1=rarely, 4=almost always). Higher scores on the Lability/Negativity sub scale indicate more difficulty managing and coping with emotions, while higher scores on the Emotion Regulation sub scale indicate better ability to self-regulate.
Time frame: Baseline, 16 week
Change in Daily Living Skills Scale Scores during treatment
Higher scores indicate better ability on the DLSS. \[Score Range: 0-53\]
Time frame: Baseline, 16 week, 2 month Follow up
Change in Open Source - Challenging Behavior scores during treatment
Higher levels indicate greater levels of challenging behavior and lower levels indicate improvement.
Time frame: Baseline, 16 weeks, 2 month Follow Up
Started Jan 2025 (actual). Primary completion is estimated for Oct 2027, 32 months after the start.
Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 32 months is above that.
Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.